Shanghai Henlius Biotech looks to raise $600m from HK IPO

New York-listed Alibaba was most likely to launch the offer as early as the third quarter.

The massive protests in Hong Kong against an unpopular China-backed extradition legislation contributed to investor unease.

The delay comes as fears rise that US-China trade tensions and Washington's new threats of tariffs against Mexico could push the global economy towards a recession.

The pricing values the company at $10.3 billion.